Do Aromatase Inhibitors Increase Testosterone?

Aromatase inhibitors do not increase testosterone directly, but they can raise testosterone levels in the body by stopping the conversion of testosterone into estrogen. This is a key distinction. The medication does not signal the body to make more testosterone. Instead, it blocks an enzyme called aromatase, which normally turns a portion of your testosterone into estradiol, a form of estrogen. When that conversion is blocked, more testosterone remains available in your bloodstream. For men with low testosterone and high estrogen, this can result in a noticeable rise in testosterone levels. However, this is not a standard first-line treatment for low testosterone, and it carries real risks that need careful consideration.

How Do Aromatase Inhibitors Work in the Body?

Aromatase inhibitors are medications originally developed to treat certain types of breast cancer in women. In women, estrogen can fuel the growth of hormone-sensitive tumors. By blocking aromatase, these drugs lower estrogen production throughout the body.

In men, the same mechanism applies but with a different effect. Testosterone is the main male sex hormone, but a small percentage of it is constantly being converted into estrogen by the aromatase enzyme. This is a normal process. When a man takes an aromatase inhibitor, that conversion slows down or stops. The testosterone that would have been converted stays in the bloodstream instead.

The result is a higher testosterone-to-estrogen ratio. Some men experience this as an increase in measured total testosterone on blood tests, even though the body’s natural production of testosterone has not changed at all.

Do Aromatase Inhibitors Increase Testosterone in Men With Low T?

For men with clinically low testosterone, aromatase inhibitors are not the standard treatment. Testosterone replacement therapy (TRT) is the usual approach. TRT directly supplies testosterone to the body through injections, gels, patches, or pellets.

Aromatase inhibitors are sometimes used off-label in specific situations. One example is a man who has low testosterone and high estrogen levels. Another is a man on TRT whose estrogen levels climb too high and cause side effects like breast tenderness or water retention. In these cases, some clinicians prescribe an aromatase inhibitor to manage estrogen rather than to boost testosterone directly.

Research on this use is limited. Some small studies suggest that aromatase inhibitors can raise testosterone levels in certain groups of men, particularly older men with low testosterone and elevated estrogen. But these studies are not large, and long-term safety data is lacking. The evidence does not support using aromatase inhibitors as a general treatment for low testosterone.

What Is the Difference Between Aromatase Inhibitors and Testosterone Replacement Therapy?

Testosterone replacement therapy adds testosterone from outside the body. It raises testosterone levels directly and reliably. It also suppresses the body’s own production of testosterone because the brain detects that enough testosterone is present and stops signaling the testes to produce more.

Aromatase inhibitors work differently. They do not add any testosterone. They only prevent the breakdown of existing testosterone into estrogen. This means the effect depends entirely on how much testosterone your body is already producing. If your natural production is very low, blocking aromatase will only produce a modest increase at best.

There is also a risk with long-term aromatase inhibitor use in men. Testosterone is not only converted into estrogen in fat tissue and elsewhere — this conversion also happens inside the testes themselves. Some research suggests that blocking aromatase inside the testes may interfere with the body’s ability to produce testosterone in the first place. This means the benefit of aromatase inhibitors may diminish over time, and testosterone levels could eventually drop.

What Are the Risks of Using Aromatase Inhibitors for Testosterone?

Using aromatase inhibitors in men is considered off-label. This means the medication is approved for one purpose (breast cancer in women) but is being used for a different purpose (managing testosterone or estrogen in men). Off-label use is legal and common, but it means the drug has not undergone the same rigorous testing for this specific use.

Potential side effects in men include:

• Joint pain and stiffness
• Mood changes, including irritability or depression
• Fatigue
• Decreased bone density over time
• Increased risk of osteoporosis
• Changes in cholesterol levels

Estrogen is not just a female hormone. In men, estrogen plays an important role in bone health, brain function, and cardiovascular health. Driving estrogen too low can create new problems even while testosterone levels rise.

There is also the question of whether raising testosterone by blocking estrogen actually improves symptoms. Many men seek treatment for fatigue, low libido, or poor mood. Some studies suggest that testosterone replacement therapy improves these symptoms. Whether aromatase inhibitors produce the same improvements is not well established. A higher testosterone number on a blood test does not automatically mean you will feel better.

Who Might Be a Candidate for Aromatase Inhibitors?

There is no broad clinical guideline recommending aromatase inhibitors for men with low testosterone. However, some specialists consider them in narrow circumstances.

One example is a man with a condition called secondary hypogonadism, where the testes are healthy but the brain is not signaling them to produce testosterone. In this situation, some clinicians use a medication called clomiphene citrate, which stimulates the brain to produce more luteinizing hormone (LH). LH then signals the testes to make more testosterone. Aromatase inhibitors have also been studied for this purpose because blocking estrogen can increase LH production as well.

Another example is a man with obesity and low testosterone. Adipose tissue contains aromatase enzymes. More body fat means more aromatase activity, which means more testosterone is being converted into estrogen. This can create a cycle where testosterone drops and estrogen rises. In this case, an aromatase inhibitor might help break that cycle. But weight loss remains the primary recommendation, and no medication replaces the benefits of reducing excess body fat.

In all cases, the decision to use an aromatase inhibitor should be made by a physician after thorough blood testing. This is not a medication to self-prescribe or obtain through an online clinic without supervision.

What Blood Tests Should You Ask For?

If you are concerned about your testosterone levels, a single total testosterone test is not enough. A proper evaluation includes:

• Total testosterone
• Free testosterone (the portion not bound to proteins)
• Estradiol (the main form of estrogen)
• LH and FSH (pituitary hormones that control testosterone production)
• Prolactin (if a pituitary issue is suspected)
• Complete blood count and metabolic panel

Normal total testosterone is generally considered to be between 300 and 1000 ng/dL, though ranges vary by laboratory. Estradiol levels in men are typically between 10 and 40 pg/mL. These numbers help a physician determine whether an aromatase inhibitor is even worth considering.

Testing should be done in the morning, as testosterone levels peak early in the day. A single low reading should be confirmed with a second test before any treatment is considered.

Key Takeaways

Aromatase inhibitors can raise testosterone levels in men, but they do so indirectly by blocking estrogen conversion. They do not stimulate testosterone production. They are not a first-line treatment for low testosterone and are not approved by the FDA for this use in men.

Testosterone replacement therapy remains the standard approach for men with clinically low testosterone. Aromatase inhibitors are a niche tool used by some specialists in specific situations, such as men with high estrogen levels or those who cannot tolerate standard TRT.

The evidence for aromatase inhibitors in men is limited. Small studies show some benefit, but long-term safety data is missing. Anyone considering this approach should work with a physician who understands the risks and can monitor blood levels regularly.